Indication
Chlamydia cervicitis
Chlamydia cervicitis is a sexually transmitted infection of the female lower reproductive tract caused by the obligate intracellular bacterium *Chlamydia trachomatis*. Read more about Chlamydia cervicitis
98 drugs 54 manufacturers
Drugs that treat it
Common Chlamydia cervicitis therapies.
E.E.S. GRANULES (erythromycin ethylsuccinate)
ZITHROMAX Z-PAK (azithromycin)
AZITHROMYCIN
AZITHROMYCIN
ERYTHROMYCIN (erythromycin base)
AZITHROMYCIN
AZITHROMYCIN
AZITHROMYCIN
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonChlamydia cervicitis is a sexually transmitted infection of the female lower reproductive tract caused by the obligate intracellular bacterium *Chlamydia trachomatis*.
Pathophysiologically, the organism infects the columnar and transitional epithelial cells of the endocervix, provoking localized mucosal inflammation.
While frequently asymptomatic, the condition is clinically characterized by mucopurulent endocervical discharge, mucosal erythema, edema, and sustained cervical friability, which often presents as postcoital bleeding or spotting.
If left untreated, the pathogen can ascend into the upper reproductive tract, significantly increasing the risk of pelvic inflammatory disease, ectopic pregnancy, chronic pelvic pain, and tubal infertility.
- nih.gov
Chlamydia cervicitis is a sexually transmitted infection of the female lower reproductive tract caused by the obligate intracellular bacterium *Chlamydia trachomatis* If left untreated, the pathogen can ascend into the upper reproductive tract, significantly increasing the risk of pelvic inflammatory disease, ectopic pregnancy, chronic pelvic pain, and tubal infertility
- nih.gov
Chlamydia cervicitis is a sexually transmitted infection of the female lower reproductive tract caused by the obligate intracellular bacterium *Chlamydia trachomatis* Pathophysiologically, the organism infects the columnar and transitional epithelial cells of the endocervix, provoking localized mucosal inflammation
- nih.gov
Pathophysiologically, the organism infects the columnar and transitional epithelial cells of the endocervix, provoking localized mucosal inflammation
- nih.gov
While frequently asymptomatic, the condition is clinically characterized by mucopurulent endocervical discharge, mucosal erythema, edema, and sustained cervical friability, which often presents as postcoital bleeding or spotting
- nih.gov
While frequently asymptomatic, the condition is clinically characterized by mucopurulent endocervical discharge, mucosal erythema, edema, and sustained cervical friability, which often presents as postcoital bleeding or spotting
- nih.gov
While frequently asymptomatic, the condition is clinically characterized by mucopurulent endocervical discharge, mucosal erythema, edema, and sustained cervical friability, which often presents as postcoital bleeding or spotting
- cdc.gov
If left untreated, the pathogen can ascend into the upper reproductive tract, significantly increasing the risk of pelvic inflammatory disease, ectopic pregnancy, chronic pelvic pain, and tubal infertility
Personalize your experience
Follow Chlamydia cervicitis and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.